Diethyl [2,2'-bipyridine]-4,4'-dicarboxylate

Catalog No. :
ACPXWG089
CAS No. :
1762-42-1
Molecular Formula :
C16H16N2O4
Molecular Weight :
300.31

IUPAC Name:diethyl [2,2'-bipyridine]-4,4'-dicarboxylate

Diethyl [2,2'-bipyridine]-4,4'-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g96%$134.00Login to see priceIn stockInquiry
25g96%$501.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameDiethyl [2,2'-bipyridine]-4,4'-dicarboxylate
IUPAC Namediethyl [2,2'-bipyridine]-4,4'-dicarboxylate
MDL No.MFCD06204732
Molecular FormulaC16H16N2O4
Molecular Weight300.31
SMILESO=C(C1=CC(C2=NC=CC(C(OCC)=O)=C2)=NC=C1)OCC
InChI KeyCTXJVXIVHPUFIP-UHFFFAOYSA-N
Synonymethyl 2-(4-ethoxycarbonylpyridin-2-yl)pyridine-4-carboxylate;4,4'-bis(ethoxycarbonly)-2,2'-bipyridine;2,2'-Bipyridinyl-4,4'-dicarboxylic acid diethyl ester;4,4'-Bis(ethoxycarbonyl)-2,2'-bipyridine;[2,2'-Bipyridine]-4,4'-dicarboxylicacid, 4,4'-diethyl ester;2,2′-Bipyridine]-4,4′-dicarboxylic acid, diethyl ester;Diethyl [2,2'-bipyridine]-4,4'-dicarboxylate
CAS No.1762-42-1
PubChem CID12088573

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACPXWG089 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACABFQ512 route compound structure diagram
    ACABFQ51297333-46-5 In Stock
  2. Then
  3. ACPXWG089 route product structure diagram
    ACPXWG0891762-42-1 In Stock
Inquiry

2. ACPXWG089 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWNQU173 route compound structure diagram
    ACWNQU17354453-93-9 In Stock
  4. Then
  5. ACPXWG089 route product structure diagram
    ACPXWG0891762-42-1 In Stock
Inquiry

Comments (0)